Unlocking the Future of the Hemostasis Products Market: Growth Rate, Key Trends, and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the Hemostasis Products market size evolved in recent years?
The market size for hemostasis products has experienced robust growth in the past years. From $1.7 billion in 2024, it is projected to expand to $1.81 billion in 2025, registering a compound annual growth rate (CAGR) of 6.7%. Factors such as the surge in surgical processes, aging demographics, a greater occurrence of hemophilia, enhanced healthcare facilities, and increased consciousness about blood coagulation conditions have contributed to the historic period’s growth.
What are the predictions for the hemp rebar market size in the coming years?
The market size of hemostasis products is projected to display robust growth in the upcoming years. By 2029, it is expected to reach $2.31 billion, expanding at a CAGR of 6.3%. Factors contributing to this growth in the projection period include the escalating demand for minimally invasive operations, a global surge in trauma cases, the broadening of hemostasis applications in chronic diseases, transition to ambulatory surgical centers, personalized medical practices, and biomarker research. Significant trends during the forecast span entail technological innovation in hemostasis, progress in hemostatic technologies, increased inclination towards minimally invasive procedures, a rise in the occurrence of chronic diseases and emphasis on biodegradable hemostatic agents.
Get your hemostasis products market report here!
https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report
What key factors are fueling the growth of the hemostasis products market?
The burgeoning occurrence of blood disorders is anticipated to spur the expansion of the hemostasis products market. Blood disorders, often known as hematologic disorders, constitute a range of medical conditions impacting the blood’s composition, function and behavior. Hemostasis products play a key role in managing various blood disorders by regulating the body’s clotting and bleeding processes. They can rectify both excessive bleeding (hemorrhage) and excessive clotting (thrombosis) associated with different blood disorders. For instance, data from the US-based Leukemia & Lymphoma Society showed an increase in the number of US citizens per 100,000 diagnosed with Leukemia – from 14.1 in 2021 to 14.3 in 2022. This growing prevalence of blood disorders, therefore, triggers the growth of the hemostasis products market. The hemostasis products market is also fueled by the escalating prevalence of cardiac disorders. These refer to a wide array of conditions and diseases that affect the heart and blood vessels. Hemostasis products are invaluable for managing bleeding linked to cardiac disorders, as well as for their prevention and treatment. These products help reduce blood loss, decreasing the necessity for blood transfusions and the likelihood of complications in cardiac disorders. For instance, a report from the American Heart Association, a US-based non-profit, recorded a 4.0% increase in the age-adjusted death rate from cardiovascular disease in January 2024, going from 224.4 per 100,000 in 2023 to 233.3 per 100,000 in 2024. Consequently, the upsurge in cardiac disorders precedes the expansion of the hemostasis products market.
How is the global hemostasis products market divided into key segments?
The hemostasis products market covered in this report is segmented –
1) By Product: Topical Hemostasis Product, Infusible Hemostasis Product, Advanced Hemostasis Product
2) By Application: Trauma, Surgery, Hemophilia, Myocardial Infarction, Other Applications
3) By End User: Hospitals, Clinics, Other End Users
Subsegments:
1) By Topical Hemostasis Product: Hemostatic Agents, Tissue Sealants, Fibrin Sealants
2) By Infusible Hemostasis Product: Platelet-Rich Plasma (PRP), Coagulation Factors, Prothrombin Complex Concentrates
3) By Advanced Hemostasis Product: Biological Adhesives, Synthetic Hemostatic Agents, Hemostatic Dressings
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13244&type=smp
Who are the key firms paving the way for growth in the hemostasis products market?
Major companies operating in the hemostasis products market report are Pfizer Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Medtronic PLC, Johnson And Johnson Pvt. Ltd., Siemens Healthineers, Becton Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Boston Scientific Corporation, F. Hoffmann-La Roche Ltd., BBraun Melsungen AG, Fresenius Kabi AG, Zimmer Biomet Holdings Inc., Olympus Corporation, Grifols S.A., Terumo BCT Inc., Smith And Nephew PLC, Ethicon Suture Laboratories, Hologic Inc., Cook Medical, Teleflex Incorporated, Integra LifeSciences Corporation, Haemonetics Corporation, Z-Medica LLC, Tricol Biomedical, Hem Con Medical Technologies Inc., Hemostasis LLC, C. R. Bard Inc., CuraMedical BV
Which trends are expected to transform the hemostasis products market?
Leading organizations in the hemostasis products market are making strides in the creation of groundbreaking drugs such as the Nexpowder endoscopic hemostasis system, acquiring approvals for a comprehensive portfolio of active and inactive hemostatic products for bleeding control. An endoscopic hemostasis system employs a specialized medical device and method to manage bleeding in the gastrointestinal (GI) tract throughout endoscopic procedures. For example, in September 2022, Medtronic PLC, a medical device company based in the United States, was granted clearance by the U.S. Food and Drug Administration for the use of the Nexpowder Endoscopic Hemostasis System to treat nonvariceal upper GI bleeding. This pioneering hemostatic product is designed for use alongside endoscopy. Moreover, it holds the potential to significantly influence the treatment of nonvariceal upper GI bleeding due to its ease of use, effectiveness, and high tolerability.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13244
What regions are contributing significantly to the growth of the hemostasis products market?
North America was the largest region in the hemostasis products market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemostasis products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Flexible Endoscopes Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/flexible-endoscopes-global-market-report
Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2024
Respiratory Inhaler Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/respiratory-inhaler-devices-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
